pB3 probe spans the major breakpoint clustering region of t(14;18) translocation, which is localized within the second exon of the bcl-2 gene (10) . The pFL-2 probe lies more than 20 kb downstream from the second exon of the bcl-2 gene and detects most t(14;18) translocations, the breakpoints of which do not fall in the major breakpoint clustering region (5) . DNA probes were s2p labeled by nick translation .
Southern Blot Analysis. High molecular weight DNA, isolated from peripheral leukemia cells and from healthy human placenta as acontrol, was digested with restriction endonucleases, run on 0 .7% agarose, and blotted to a nitrocellulose filter as described (9) .
Construction of the Genomic DNA Libraries. DNAs were partially digested with Sau3AI enzyme, and DNA fragments between 15 and 23 kb were ligated with XEMBL3A phage vector and packaged in vitro as described (9) .
DNA Sequencing. Nucleotide sequences were determined by the dideoxy chain termination method as described (11) .
Results and Discussion 32 fresh specimens of CLL cases were collected from the National Institutes of Health (two cases) (9) , Scripps Clinic (20 cases), and the Mayo Clinic (10 cases), and screened for bcl-2 gene rearrangement using Southern blot analysis . The bcl-2 gene probes used include pBl6 (10) (a part of the bcl-2 first exon), pB3 (10) (the major breakpoint clustering region of the t(14;18) translocation), and pFL-2 (5) (the minor breakpoint clustering region) . Of the 32 CLL samples, three cases (CLL1446 [9] , CLL2, and CLL26) showed the rearrangements of the bcl-2 gene that were detected with the pB16 probe. No case showed any rearrangement with the pB3 and pFL-2 probe. Fig. 1 shows a Southern blot analysis of CLL2 (Fig . 1 A) and CLL26 ( 1 B) DNAs with the pB16 probe, in which both revealed distinct rearranged fragments with Bam HI and Hind III restriction enzymes. Thus, a significant fraction (-10%) of CLL involves the rearrangement of the bcl-2 first exon region .
Genomic libraries were prepared from CLL2 and CLL26 DNAs using AEMBL3A vector and screened with pB16 probe as described (9) . The XC2 and XC26 were representative clones containing the rearranged bcl-2 gene of CLL2 and CLL26, respectively (Fig. 2) . A comparison of the restriction maps of these clones with maps of normal bcl-2, IgX, and Iga genes proved physical linkage between the bcl-2 gene and IgX locus in XC2 clone, and Igu locus in XC26 clone, in a head-to-head configuration . We determined the nucleotide sequences in the vicinity of the breakpoints and the relevant portions of the bcl-2 and IgLs loci (Fig. 3) . The breakpoints on chromosome 18 were mapped within the 5' flanking region ofthe bcl-2 gene (-1,100 and 600 by upstream from the 5' end of cDNA [10] in CLL2 and CLL26, respectively). In addition to these two CLL samples, a third (CLL1446) has been shown to carry the bcl-2/Iga rearrangement, the breakpoint ofwhich was mapped -50 by upstream from the 5' end of cDNA (10), suggesting a hot spot for rearrangements in CLL at the 5' flanking region of bcl-2 gene. The breakpoints on IgL loci were mapped within the VX (subclass III) of the VXJX joining product in CLL2 (Fig .  3 A) and within the 5' flanking region ofJK4 in CLL26 (Fig. 3 B) . Analysis of the reciprocal recombinant of the XC26 clone has shown that a Vic gene rearranged to JK3 (Fig. 2) . It is interesting that the breakpoints of the bcl-2/IgL juxtapositions in CLL2 and CLL26 are located near (-20 and 150 bp, respectively) the VJ joining sites. This might reflect that the VJ joining product could remain activated, and undergo further rearrangements with new V genes, thus producing additional variations in the VJ product. As described above, no case of CLL showed any rearrangement with the bcl-2 probes that detect the major and minor breakpoint clustering regions of the t(14 ;18) translocation. Conversely, in follicular lymphoma the bcl-2 gene is commonly rearranged within these two breakpoint clustering regions (1, 12) , except in one case (FL989) (13) . In the case of FL989, the 5' flanking region of the bcl-2 gene was rearranged but juxtaposed to IgH locus (13) . These results suggest that rearrangement of bcl-2 gene occurs preferentially at its 5' flanking region in CLL and results in the bcl-2/IgL juxtaposition. This situation seems to be characteristic of CLL because none of 22 cases of multiple myeloma samples tested thus far have shown the bcl-2 gene rearrangement (Adachi, M., and Y. Tsujimoto, unpublished observation).
We are intrigued to find that two different B cell tumors, follicular lymphoma and CLL, are characterized by chromosome translocations involving the same bcl-2 gene but different Ig loci . Several explanations can be advanced . The bcl-2 gene might be activated in different ways by IgH and IgL genes at the transcriptional level or through mutations of the protein coding region . The second possibility is based on the timing of bcl-2 gene activation . The bcl-2 gene could be activated at a pre-B stage in follicular lymphoma when IgH gene is rearranged (14) and at a more mature B cell stage in CLL when IgL gene is rearranged, which in turn produces the expanded pool of the prefollicular lymphoma or pre-CLL cells. The expansion of activated B cells by the bcl-2 gene could enhance the chance of acquiring additional genetic alterations of different genes that define the nature of B cell tumors.
Regardless of the mechanism of the bcl-2 gene activation, our finding demonstrates that the choice of breakpoint regions of an oncogene and of Ig genes as an activator can characterize different malignancies of the B cell lineage .
Summary
Most of human follicular lymphomas possess the t(14;18) chromosome translocation thatjuxtaposes the IgH gene to the 3' region of bcl-2 in a head-to-tail configuration. Here we show that the rearrangement of the bcl-2 gene occurs in a significant fraction (N10%) of B cell CLL. In all cases analyzed, breakpoints on chromosome 18 clustered at the 5' flanking region ofthe bcl-2 gene, and no rearrangements were found at the major or minor breakpoint clustering region (3' region of bcl-2 gene) typical of the t(14;18) chromosome translocation . All of the rearranged bcl-2 genes werejuxtaposed with the IgX or « genes in a head-to-head configuration . These results imply that the bcl-2 gene is preferentially linked to the IgL genes in CLL and could function in leukemogenesis .
